Skip to content

An interventional study to evaluate the use of imaging tool during diabetic retinal (inner layer of eye) detachment surgery to reduce the risk of re-surgery

Use of microscopic integrated optical coherence tomography to reduce post-surgical epiretinal membrane formation in eyes undergoing vitrectomy for tractional retinal detachment due to diabetic retinopathy. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068825
Enrollment
64
Registered
2024-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Use of microscopic integrated optical coherence tomography to reduce post-surgical epiretinal membrane formation in eyes undergoing vitrectomy for tractional retinal detachment due to d

Sponsors

Advanced Eye Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: type 1 and 2 DM who require vitrectomy for diabetic TRD willing for preoperative injection of Ranibizumab phakic or pseudophakic willing for follow up period of 3 months

Exclusion criteria

Exclusion criteria: aphakic patients NVI/NVG history of prior vitrectomy combined retinal detachment requiring silicone oil tamponade in case of intraoperative break formation unwilling for preoperative injection of Ranibizumab history of stroke/MI 3 months before injection of Ranibizumab unable to maintain a particular posture after surgery, if required unwilling to be a part of the study

Design outcomes

Primary

MeasureTime frame
we will compare the incidence of epiretinal membrane formation between group A and group B group A- MIOCT will be used at the end of surgery to look for preretinal residual membranes. They will be removed intraoperatively using MIOCT. group B- conventional ILM peeling groupTimepoint: day 1, 1 week, 1 month and at 3 months.

Secondary

MeasureTime frame
comparison of visual gain and any complications such as postoperative vitreous cavity haemorrhage between the two groupsTimepoint: at 3 months

Countries

India

Contacts

Public ContactRamandeep Singh

Post graduate institute of medical education and research, Chandigarh

ramandeeppgi@gmail.com9463001620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026